A Study to Evaluate Safety, Feasibility, Efficacy of Multiple Dosing With VB10.NEO Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Condition:   Locally Advanced or Metastatic Solid Tumours
Intervention:   Drug: VB10.NEO
Sponsor:   Vaccibody AS
Recruiting

https://ift.tt/2Jo5BeY